Site Logo
  1. Home
  2. Past Issues
  3. Summary Vol.81 Issue 1 / 2018
  4. Article
Original Articles
Views

Arq. Bras. Oftalmol. 2018; 81 (1): 10.5935/0004-2749.20180005

Total: 1234

Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?

Seyhan Dikci; Osman Melih Ceylan; Soner Demirel; Turgut Yılmaz

DOI: 10.5935/0004-2749.20180005

Altmetric

No results

Dimensions


Read in Portuguese XML Print PDF English
Open Access
Share

How to cite this article:

Dikci S, Ceylan OM, Demirel S, Yılmaz T. Qual a dose de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva: menor ou maior dose?. Arq. Bras. Oftalmol. 2018;81(1):. 10.5935/0004-2749.20180005
Export citation